Treatment and clinical outcomes of pediatric autoimmune hemolytic anemia: real-world single-center data from Korea
Background Autoimmune hemolytic anemia (AIHA) is rare and characterized by hemolytic anemia with a positive direct antiglobulin test result after the exclusion of other causes. While adults often relapse within 1 year of first-line steroid therapy, children generally respond well. However, current t...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Pediatric Society
2025-07-01
|
Series: | Clinical and Experimental Pediatrics |
Subjects: | |
Online Access: | http://e-cep.org/upload/pdf/cep-2024-02026.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|